Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
GLAXOSMITHKLINE NZ LIMITED,Recombinant Zoster Vaccine,"Prevention of herpes zoster and post-herpetic neuralgia, people at 50 years of age and a catch-up program  for people 51 to 64 years",Recombinant Zoster Vaccine (SHINGRIX),Community and Hospital,National Immunisation Schedule
